Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19

NCT04407182 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid-19
Sars-CoV2
Diabete Mellitus
Cardiopathy
Pulmonary Disease
Renal Disease
Liver Diseases

Interventions

DIETARY_SUPPLEMENT: Viusid and Asbrip

Sponsor

Catalysis SL